Beam Therapeutics BEAM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Business | ||||||
| Employee Related Expenses | $32.87M+12.4% | $32.86M+20.4% | $27.64M+15.6% | $27.62M+20.0% | $29.24M+19.0% | |
| External Research And Development Expenses | $30.08M-12.6% | $34.82M+8.1% | $33.57M+0.4% | $39.89M+64.8% | $34.42M+35.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Beam Therapeutics break its business down?
- Beam Therapeutics (BEAM) reports research and development expense by business across 2 parts — Employee Related Expenses and External Research And Development Expenses. Each is extracted from the segment footnotes and tracked over time.
- Where does Beam Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Beam Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
